Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed the v3.4.3 entry.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry has been added to the record history, documenting an update to the study status.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision adds results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with updated documentation. It also updates Study Status and other study data sections.SummaryDifference2%

- Check65 days agoChange DetectedAdded a site-wide notice about funding and operating status. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check72 days agoChange DetectedThe history page now includes a Show glossary option, color-coded additions and deletions (green/red), and a revision footer showing 'Revision: v3.4.0'.SummaryDifference0.8%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.